Clinical Trial Update: Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update of SHR-1210 in combination with chemotherapy in advanced esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• SHR-1210 (camrelizumab)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Esophageal Cancer | Phase 3 | Status: COMPLETED